1 Followers
recast:farcaster://casts/0xbb5c2ebdcef3f8a782111f74c4aea6ee4429f45f0ed5b0397dc7225e2cddb750
Olin Biologics announced that it has received a Clinical Trial Approval Notice from the National Medical Products Administration regarding the quadrivalent influenza virus split vaccine, agreeing to conduct clinical trials related to the prevention of influenza related types in populations aged 6 months and above.
On March 24th, the launch ceremony of the "Angel Journey - Screening and Rescue Action for Children with Congenital Heart Disease" by the Chinese Red Cross Foundation was held at the Tumushuke City General Hospital of the Third Division of the Xinjiang Production and Construction Corps.